Search
See the whole debate « Previous speaker Next speaker »
9:00 am
Dr. Gabriel Scally:
That sums up our concern. As we said, the decision to view 18 months as being the cut-off point for clinical impact was undoubtedly flawed and it is hard to see the logic for it. That is what we said in the report.
No comments
Log in or join to post a public comment.
No comments